yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q38429845-94A64568-DC9E-476A-9B26-4CD04E5EC109
Q38429845-94A64568-DC9E-476A-9B26-4CD04E5EC109
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38429845-94A64568-DC9E-476A-9B26-4CD04E5EC109
Are SGLT2 inhibitors reasonable antihypertensive drugs and renoprotective?
P2860
Q38429845-94A64568-DC9E-476A-9B26-4CD04E5EC109
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38429845-94A64568-DC9E-476A-9B26-4CD04E5EC109
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9a95f4841eb53c7aca0caae863cc8f692ac38cd0
P2860
Update on developments with SGLT2 inhibitors in the management of type 2 diabetes